| Organism name | Panax ginseng |
|---|---|
| Genus | Panax |
| Family | Araliaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Panax ginseng |
|---|---|
| Linked NCBI taxonomy ID | 4054 |
| Linked level | species |
| Family in NCBI taxonomy | Araliaceae |
|---|---|
| ID | 4050 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | asterids |
|---|---|
| ID | 71274 |
| Species | Activity |
|---|---|
| Panax ginseng C.A. Mey. | Adaptogen |
| Panax ginseng C.A. Mey. | Adrenergic |
| Panax ginseng C.A. Mey. | Alterative |
| Panax ginseng C.A. Mey. | Analgesic |
| Panax ginseng C.A. Mey. | Antiaggregant |
| Panax ginseng C.A. Mey. | Antiaging |
| Panax ginseng C.A. Mey. | Antialcoholic |
| Panax ginseng C.A. Mey. | Antiarrhythmic |
| Panax ginseng C.A. Mey. | Anticancer |
| Panax ginseng C.A. Mey. | Anticatecholamine |
| Panax ginseng C.A. Mey. | Anticholinergic |
| Panax ginseng C.A. Mey. | Anticonvulsant |
| Panax ginseng C.A. Mey. | Antidepressant |
| Panax ginseng C.A. Mey. | Antidiuretic |
| Panax ginseng C.A. Mey. | Antifatigue |
| Panax ginseng C.A. Mey. | Antihepatomic |
| Panax ginseng C.A. Mey. | Antiinflammatory |
| Panax ginseng C.A. Mey. | Antiischemic |
| Panax ginseng C.A. Mey. | Antimitogenic |
| Panax ginseng C.A. Mey. | Antioxidant |
| Panax ginseng C.A. Mey. | Antiprolactin |
| Panax ginseng C.A. Mey. | Antiprostatic |
| Panax ginseng C.A. Mey. | Antipsychotic |
| Panax ginseng C.A. Mey. | Antiradiation |
| Panax ginseng C.A. Mey. | Antiseptic |
| Panax ginseng C.A. Mey. | Antithromboxane |
| Panax ginseng C.A. Mey. | Antitumor |
| Panax ginseng C.A. Mey. | Antiulcer |
| Panax ginseng C.A. Mey. | Antiviral |
| Panax ginseng C.A. Mey. | Antiwrinkle |
| Panax ginseng C.A. Mey. | Anxiolytic |
| Panax ginseng C.A. Mey. | Aperitif |
| Panax ginseng C.A. Mey. | Aphrodisiac |
| Panax ginseng C.A. Mey. | Apoptotic |
| Panax ginseng C.A. Mey. | Bitter |
| Panax ginseng C.A. Mey. | Cardiotonic |
| Panax ginseng C.A. Mey. | Carminative |
| Panax ginseng C.A. Mey. | Caspase Stimulator |
| Panax ginseng C.A. Mey. | Chemopreventive |
| Panax ginseng C.A. Mey. | Circulostimulant |
| Panax ginseng C.A. Mey. | CNS Sedative |
| Panax ginseng C.A. Mey. | CNS Stimulant |
| Panax ginseng C.A. Mey. | Corticotrophinogenic |
| Panax ginseng C.A. Mey. | Cytotoxic |
| Panax ginseng C.A. Mey. | Demulcent |
| Panax ginseng C.A. Mey. | Diuretic |
| Panax ginseng C.A. Mey. | Elevates HDL-Cholesterol |
| Panax ginseng C.A. Mey. | Emetic |
| Panax ginseng C.A. Mey. | Energizer |
| Panax ginseng C.A. Mey. | Estrogenic |
| Panax ginseng C.A. Mey. | Ethanolytic |
| Panax ginseng C.A. Mey. | Expectorant |
| Panax ginseng C.A. Mey. | Fatigue |
| Panax ginseng C.A. Mey. | Gonadotropic |
| Panax ginseng C.A. Mey. | Hemopoietic |
| Panax ginseng C.A. Mey. | Hepatoprotective |
| Panax ginseng C.A. Mey. | Hepatotonic |
| Panax ginseng C.A. Mey. | Hyperglycemic |
| Panax ginseng C.A. Mey. | Hypertensive |
| Panax ginseng C.A. Mey. | Hypocholesterolemic |
| Panax ginseng C.A. Mey. | Hypoglycemic |
| Panax ginseng C.A. Mey. | Hypotriglyceridemic |
| Panax ginseng C.A. Mey. | Immunostimulant |
| Panax ginseng C.A. Mey. | Interferonigenic |
| Panax ginseng C.A. Mey. | Memorigenic |
| Panax ginseng C.A. Mey. | Mineralcorticoid |
| Panax ginseng C.A. Mey. | Mitogenic |
| Panax ginseng C.A. Mey. | Negative Chronotropic |
| Panax ginseng C.A. Mey. | Negative Inotropic |
| Panax ginseng C.A. Mey. | Nervine |
| Panax ginseng C.A. Mey. | Neurotonic |
| Panax ginseng C.A. Mey. | Nicotinic |
| Panax ginseng C.A. Mey. | NKC-Genic |
| Panax ginseng C.A. Mey. | NO-Genic |
| Panax ginseng C.A. Mey. | Nootropic |
| Panax ginseng C.A. Mey. | Osteoprotective |
| Panax ginseng C.A. Mey. | Phagocytotic |
| Panax ginseng C.A. Mey. | Positive Inotropic |
| Panax ginseng C.A. Mey. | Radioprotective |
| Panax ginseng C.A. Mey. | Respirastimulant |
| Panax ginseng C.A. Mey. | Roborant |
| Panax ginseng C.A. Mey. | Secretagogue |
| Panax ginseng C.A. Mey. | Sedative |
| Panax ginseng C.A. Mey. | Serotonilytic |
| Panax ginseng C.A. Mey. | Sialagogue |
| Panax ginseng C.A. Mey. | Spermatogenic |
| Panax ginseng C.A. Mey. | Stomachic |
| Panax ginseng C.A. Mey. | Testosteronigenic |
| Panax ginseng C.A. Mey. | Thymoleptic |
| Panax ginseng C.A. Mey. | Tonic |
| Panax ginseng C.A. Mey. | Tranquilizer |
| Panax ginseng C.A. Mey. | Ulcerogenic |
| Panax ginseng C.A. Mey. | Vasodilator |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00005157
|
Panasenoside
|
CHEMBL500233
CHEMBL1375795 CHEMBL2032411 |
12 / 2 / 2 | No. 1 | No. 15 |
|
||
|
C00030447
|
Gypenoside XVII
|
CHEMBL504441
|
No. 11 | No. 51 |
|
|||
|
C00030844
|
Notoginsenoside Fe
|
No. 11 | No. 51 |
|
||||
|
C00030398
|
Ginsenoside Rd
|
CHEMBL473659
|
C049863
|
2 / 0 / 0 | 0 / 1 | No. 11 | No. 51 |
|
|
C00031098
|
Pseudoginsenoside F8
|
No. 11 | No. 51 |
|
||||
|
C00003518
|
Ginsenoside Re
|
CHEMBL510095
|
C049864
|
2 / 0 / 0 | 0 / 1 | No. 11 | No. 51 |
|
|
C00033154
|
Majoroside F4
|
No. 32 | No. 51 |
|
||||
|
C00003520
|
Ginsenoside Rg1
|
CHEMBL501637
CHEMBL1977916 |
C035054
|
5 / 6 | No. 32 | No. 51 |
|
|
|
C00032815
|
Ginsenoside F5
/ Chikusetsusaponin L8 |
CHEMBL583152
|
2 / 0 / 0 | No. 32 | No. 51 |
|
||
|
C00032990
|
Ginsenoside Rg7
|
No. 32 | No. 51 |
|
||||
|
C00003519
|
Ginsenoside Rf
|
CHEMBL1773987
|
C055328
|
1 / 0 | No. 32 | No. 51 |
|
|
|
C00030399
|
Panaxoside Rg2
/ Ginsenoside Rg2 |
CHEMBL505747
CHEMBL1095005 CHEMBL1095006 CHEMBL1475728 |
C026474
|
5 / 0 / 0 | 7 / 2 | No. 32 | No. 51 |
|
|
C00033153
|
Majoroside F2
|
No. 32 | No. 51 |
|
||||
|
C00030390
|
Ginsenoside F3
|
CHEMBL1095004
|
2 / 0 / 0 | No. 32 | No. 51 |
|
||
|
C00030254
|
Floralginsenoside A
|
No. 32 | No. 51 |
|
||||
|
C00030255
|
Floralginsenoside B
|
No. 32 | No. 51 |
|
||||
|
C00030256
|
Floralginsenoside C
/ (+)-Floralginsenoside C |
No. 32 | No. 51 |
|
||||
|
C00030257
|
Floralginsenoside D
|
No. 32 | No. 51 |
|
||||
|
C00030258
|
Floralginsenoside E
/ (+)-Floralginsenoside E |
No. 32 | No. 51 |
|
||||
|
C00030389
|
Ginsenoside F2
|
CHEMBL1095007
|
2 / 0 / 0 | No. 32 | No. 51 |
|
||
|
C00030259
|
Floralginsenoside F
/ (+)-Floralginsenoside F |
No. 32 | No. 51 |
|
||||
|
C00030388
|
Ginsenoside F1
|
CHEMBL584011
|
C055327
|
No. 99 |
|
|||
|
C00032992
|
Ginsenoside Rh6
/ (+)-Ginsenoside Rh6 |
No. 99 |
|
|||||
|
C00032991
|
Ginsenoside Rh5
|
CHEMBL454530
|
No. 99 |
|
||||
|
C00032994
|
Ginsenoside Rh8
/ (+)-Ginsenoside Rh8 |
No. 99 |
|
|||||
|
C00032995
|
Ginsenoside Rh9
|
No. 99 |
|
|||||
|
C00032993
|
Ginsenoside Rh7
/ (+)-Ginsenoside Rh7 |
No. 99 |
|
|||||
|
C00021836
|
Panasinsanol A
|
C053938
|
No. 161 | No. 38 |
|
|||
|
C00021835
|
Panasinsanol B
|
C053937
|
No. 161 | No. 38 |
|
|||
|
C00021833
|
beta-Panasinsene
/ beta-Panasinsanene |
No. 365 | No. 38 |
|
||||
|
C00021834
|
alpha-Panasinsanene
|
No. 365 | No. 38 |
|
||||
|
C00021986
|
beta-Neoclovene
|
No. 365 | No. 38 |
|
||||
|
C00031489
|
1,8-Heptadecadiene-4,6-diyne-3,10-diol
|
CHEMBL463807
CHEMBL448210 |
C056818
|
No. 940 | No. 69 |
|
||
|
C00001284
|
Panaxynol
/ Falcarinol / (-)-Falcarinol |
CHEMBL71260
CHEMBL368712 |
C018541
|
0 / 2 | No. 940 | No. 69 |
|
|
|
C00002682
|
Vanillic acid
/ 3-Methoxy-4-hydroxybenzoic acid |
CHEMBL120568
|
D014641
|
5 / 3 / 3 | 5 / 0 | No. 1073 |
|
|
|
C00000100
|
IAA
/ Indole-3-acetic acid |
CHEMBL82411
|
C030737
|
3 / 0 / 0 | 2 / 1 | No. 1432 | No. 4 |
|
|
C00030922
|
Panaxydol
/ (-)-Panaxydol |
C055778
|
6 / 1 | No. 3682 |
|
|||
|
C00000101
|
IAA methyl ester
/ Methyl indole-3-acetate |
No. 4225 |
|
|||||
|
C00001756
|
Perlolyrine
/ Tribulusterine |
CHEMBL501991
|
C055781
|
No. 5379 | No. 4 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P11387 | DNA topoisomerase 1 | Isomerase | C00003518 C00030389 C00030390 C00030398 C00030399 C00032815 | 0 / 0 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003518 C00030389 C00030390 C00030398 C00030399 C00032815 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00002682 C00005157 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00005157 C00030399 | 0 / 0 |
| P15121 | Aldose reductase | Enzyme | C00002682 | 0 / 0 |
| P06746 | DNA polymerase beta | Enzyme | C00005157 | 0 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00005157 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00005157 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00005157 | 0 / 0 |
| P42858 | Huntingtin | Unclassified protein | C00002682 | 1 / 1 |
| Q16773 | Kynurenine--oxoglutarate transaminase 1 | Enzyme | C00000100 | 0 / 0 |
| P02768 | Serum albumin | Secreted protein | C00000100 | 0 / 0 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00005157 | 1 / 1 |
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00030399 | 0 / 0 |
| Q9HBH1 | Peptide deformylase, mitochondrial | Enzyme | C00000100 | 0 / 0 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00030399 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00002682 | 1 / 1 |
| P51580 | Thiopurine S-methyltransferase | Enzyme | C00002682 | 1 / 1 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00005157 | 1 / 1 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00005157 | 0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00005157 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00005157 | 0 / 0 |
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00005157 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 3757 | KCNH2, ERG1, HERG, HERG1, Kv11.1, LQT2, SQT1 | potassium voltage-gated channel, subfamily H (eag-related), member 2 |
C00003519
C00003520
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003520
C00030922
|
| 200186 | CRTC2, TORC-2, TORC2 | CREB regulated transcription coactivator 2 |
C00030399
|
| 8431 | NR0B2, SHP, SHP1 | nuclear receptor subfamily 0, group B, member 2 |
C00030399
|
| 5105 | PCK1, PEPCK-C, PEPCK1, PEPCKC | phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32) |
C00030399
|
| 10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00030399
|
| 6794 | STK11, LKB1, PJS, hLKB1 | serine/threonine kinase 11 (EC:2.7.11.1) |
C00030399
|
| 196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000100
|
| 405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00000100
|
| 898 | CCNE1, CCNE | cyclin E1 |
C00003520
|
| 1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00003520
|
| 92579 | G6PC3, SCN4, UGRP | glucose 6 phosphatase, catalytic, 3 (EC:3.1.3.9) |
C00030399
|
| 2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00030399
|
| 4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00003520
|
| 174 | AFP, FETA, HPAFP | alpha-fetoprotein |
C00030922
|
| 213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00030922
|
| 3397 | ID1, ID, bHLHb24 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
C00030922
|
| 3398 | ID2, GIG8, ID2A, ID2H, bHLHb26 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
C00030922
|
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00030922
|
| 4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00002682
|
| 54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002682
|
| 54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002682
|
| 54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002682
|
| 54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002682
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #143100 | Huntington disease; hd |
P42858
|
| #610460 | Thiopurine s-methyltransferase deficiency |
P51580
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
| KEGG | name | UniProt |
|---|---|---|
| H00026 | Endometrial Cancer |
P03372
(marker)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00964 | Thiopurine S-methyltransferase deficiency (TPMT deficiency) |
P51580
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D006948 | Hyperkinesis |
C00030399
C00003520 C00003518 |
| D003928 | Diabetic Nephropathies |
C00003520
|
| D019970 | Cocaine-Related Disorders |
C00030399
|
| D002545 | Brain Ischemia |
C00001284
|
| D056486 | Drug-Induced Liver Injury |
C00000100
|
| D003704 | Dementia |
C00003520
|
| D015427 | Reperfusion Injury |
C00001284
|
| D007249 | Inflammation |
C00003520
|
| D007859 | Learning Disorders |
C00003520
|
| D008569 | Memory Disorders |
C00003520
|
| D007674 | Kidney Diseases |
C00030398
|
| D006528 | Carcinoma, Hepatocellular |
C00030922
|